Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3Gynecologic 1

Conditions

Prostatic Neoplasms 3

Interventions

Magnetic Resonance Spectroscopy 98Specimen Handling 79pembrolizumab 75enzalutamide 63Nivolumab 59Gemcitabine 54Docetaxel 50apalutamide 42Radiosurgery 41Abiraterone Acetate 40Androgen Antagonists 39Prednisone 38Biopsy 37darolutamide 35Cisplatin 35cabozantinib 31Radiotherapy 31Carboplatin 28Pluvicto 27abiraterone 26enfortumab vedotin 24Ipilimumab 24Radiation 23durvalumab 22atezolizumab 22Leuprolide 20olaparib 18X-Rays 18Standard of Care 18avelumab 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Electroporation × Genitourinary × 90 days × Clear all
NCT07623941 2026-06-03

CUIMC Focal Therapy Registry

Columbia University

Recruiting
1,000 enrolled
Genitourinary

Prostatic Neoplasms

NCT04972097 2026-06-02

PRESERVE

Angiodynamics, Inc.

Phase NA Completed
121 enrolled 19 charts
Genitourinary

Prostatic Neoplasms

NCT05345444 2026-03-25

RTIRE

Weill Medical College of Cornell University

Phase NA Active not recruiting
48 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡